118 Hematologic Malignancies/Stem Cell Transplantation Case Conference (010622)_NOT ACCREDITED

Dallas, TX US
January 6, 2022

This conference provides a forum for interaction that promotes discussion as well as presentation by Faculty and guest speakers.

Target Audience

Hematology Faculty, Fellows, PAs, APNs and other staff

Learning Objectives

At the conclusion of this activity, the participant should be able to: (1) Determine the proper management of the patient population based on the presented cases; (2) Understand the impact of recent literature on patient care; (3) Incorporate the advancements in the care of Hematological Malignancies treatments; (4) Utilize the updates on research and new research protocols in treatment of patients.

Course summary
Available credit: 
  • 1.50 AMA
  • 1.50 Attendance
Course opens: 
01/06/2022
Course expires: 
01/06/2022
Event starts: 
01/06/2022 - 7:15am CST
Event ends: 
01/06/2022 - 9:00am CST
Cost:
$0.00
Part of: 
118 Lymphoma Board/Malignant Hematology DOT 2021
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
St. Paul 8 South Conference Room (BMT)
Dallas, TX 75390
United States
Committee member(s)

Farrukh Awan

has a financial relationship (Professional Services) with Celgene;.
has a financial relationship (Professional Services) with Verastem;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with Astrazeneca;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Medscape;.
has a financial relationship (Professional Services) with Dava Oncology;.
has a financial relationship (Professional Services) with Karyopharm;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Pharmacyclics;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with Lymphoma Research Foundation;.
has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Leukemia Lymphoma Society;.
has a financial relationship (Professional Services) with MEI pharma;.
has a financial relationship (Professional Services) with Blueprint Medicine;.
has a financial relationship (Professional Services) with Incyte;.
has a financial relationship (Professional Services) with Gilead;.
has a financial relationship (Professional Services) with Clinical Care Options;.
has a financial relationship (Professional Services) with Med Learning Group;.

Weina Chen, MD, PhD

has no relevant financial relationships to disclose at this time.

Jesse Jaso, M.D.

has no relevant financial relationships to disclose at this time.

Asha Kandathil

has no relevant financial relationships to disclose at this time.

Kiran Kumar, MD, MBA

has no relevant financial relationships to disclose at this time.
Course Director(s)

Robert Collins, Professor of Internal Medicine

has no relevant financial relationships to disclose at this time.

Praveen Ramakrishnan Geethakumari, MD, MS

has a financial relationship (Professional Services) with Kite Pharma ;.
Planner(s)

Fatma Kalkan

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.50 AMA
  • 1.50 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.